Topical Ruxolitinib Effective for Vitiligo in Adolescents ...Middle East

Medscape - News
Ruxolitinib cream is under review at the US Food and Drug Administration for treating vitiligo in patients ages 12 years and older; the agency is expected to make a decision by July 18. Medscape Medical News

Hence then, the article about topical ruxolitinib effective for vitiligo in adolescents was published today ( ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Topical Ruxolitinib Effective for Vitiligo in Adolescents )

Apple Storegoogle play

Last updated :

Also on site :



Latest News